Mk-7246
Title | Journal |
---|---|
UGT2B17 genetic polymorphisms dramatically affect the pharmacokinetics of MK-7246 in healthy subjects in a first-in-human study. | Clinical pharmacology and therapeutics 20120701 |
CRTH2 antagonist MK-7246: a synthetic evolution from discovery through development. | The Journal of organic chemistry 20120302 |
Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases. | Journal of medicinal chemistry 20111027 |
New indole amide derivatives as potent CRTH2 receptor antagonists. | Bioorganic & medicinal chemistry letters 20110601 |
Azaindoles as potent CRTH2 receptor antagonists. | Bioorganic & medicinal chemistry letters 20110115 |
Pharmacological characterization of MK-7246, a potent and selective CRTH2 (chemoattractant receptor-homologous molecule expressed on T-helper type 2 cells) antagonist. | Molecular pharmacology 20110101 |
Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases. | Bioorganic & medicinal chemistry letters 20110101 |